BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7595025)

  • 1. Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages.
    Limper AH; Crouch EC; O'Riordan DM; Chang D; Vuk-Pavlovic Z; Standing JE; Kwon KY; Adlakha A
    J Lab Clin Med; 1995 Nov; 126(5):416-22. PubMed ID: 7595025
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant protein binding to Pneumocystis carinii organisms.
    Pottratz ST
    J Lab Clin Med; 1995 Nov; 126(5):414-5. PubMed ID: 7595024
    [No Abstract]   [Full Text] [Related]  

  • 3. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages.
    O'Riordan DM; Standing JE; Kwon KY; Chang D; Crouch EC; Limper AH
    J Clin Invest; 1995 Jun; 95(6):2699-710. PubMed ID: 7769109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of surfactant protein D in the lung during Pneumocystis carinii pneumonia.
    Limper AH; O'Riordan DM; Vuk-Pavlovic Z; Crouch EC
    J Eukaryot Microbiol; 1994; 41(5):98S. PubMed ID: 7804292
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
    Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
    J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
    Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
    Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii.
    McCormack FX; Festa AL; Andrews RP; Linke M; Walzer PD
    Biochemistry; 1997 Jul; 36(26):8092-9. PubMed ID: 9201957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate recognition domain of surfactant protein D mediates interactions with Pneumocystis carinii glycoprotein A.
    Vuk-Pavlovic Z; Standing JE; Crouch EC; Limper AH
    Am J Respir Cell Mol Biol; 2001 Apr; 24(4):475-84. PubMed ID: 11306442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A.
    Zimmerman PE; Voelker DR; McCormack FX; Paulsrud JR; Martin WJ
    J Clin Invest; 1992 Jan; 89(1):143-9. PubMed ID: 1530850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro.
    Koziel H; Phelps DS; Fishman JA; Armstrong MY; Richards FF; Rose RM
    Am J Respir Cell Mol Biol; 1998 Jun; 18(6):834-43. PubMed ID: 9618388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages.
    Williams MD; Wright JR; March KL; Martin WJ
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):232-8. PubMed ID: 8845173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of plasminogen activator by alveolar macrophages in experimental Pneumocystis carinii pneumonia.
    Angelici E; Contini C; Spezzano M; Romani R; Carfagna P; Serra P; Canipari R
    J Eukaryot Microbiol; 1999; 46(5):149S. PubMed ID: 10519296
    [No Abstract]   [Full Text] [Related]  

  • 13. Surfactant changes during experimental pneumocystosis are related to Pneumocystis development.
    Aliouat EM; Escamilla R; Cariven C; Vieu C; Mullet C; Dei-Cas E; Prévost MC
    Eur Respir J; 1998 Mar; 11(3):542-7. PubMed ID: 9596099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid.
    Sternberg RI; Whitsett JA; Hull WM; Baughman RP
    J Lab Clin Med; 1995 Apr; 125(4):462-9. PubMed ID: 7706901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice.
    Atochina EN; Gow AJ; Beck JM; Haczku A; Inch A; Kadire H; Tomer Y; Davis C; Preston AM; Poulain F; Hawgood S; Beers MF
    J Infect Dis; 2004 Apr; 189(8):1528-39. PubMed ID: 15073692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in surfactant protein A form and clearance during Pneumocystis pneumonia.
    Lasbury ME; Durant PJ; Wang SH; Zhang C; Liao CP; Tschang D; Lee CH
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S119-21. PubMed ID: 17169024
    [No Abstract]   [Full Text] [Related]  

  • 17. Pneumocystosis in humans or in corticosteroid-untreated animal models: interactions between pulmonary surfactant changes and Pneumocystis carinii in vivo or in vitro growth.
    Prevost MC; Aliouat EM; Escamilla R; Dei-Cas E
    J Eukaryot Microbiol; 1997; 44(6):58S. PubMed ID: 9508443
    [No Abstract]   [Full Text] [Related]  

  • 18. Alveolar macrophage and glycoprotein responses to Pneumocystis carinii.
    Limper AH
    Semin Respir Infect; 1998 Dec; 13(4):339-47. PubMed ID: 9872631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis carinii enhances soluble mannose receptor production by macrophages.
    Fraser IP; Takahashi K; Koziel H; Fardin B; Harmsen A; Ezekowitz RA
    Microbes Infect; 2000 Sep; 2(11):1305-10. PubMed ID: 11018446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of lung surfactant protein A with alveolar macrophages.
    Ohmer-Schröck D; Schlatterer C; Plattner H; Schlepper-Schäfer J
    Microsc Res Tech; 1993 Dec; 26(5):374-80. PubMed ID: 8286783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.